Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Andrew Trister, Chief Scientific Officer at Verily
For the August episode, we discuss some recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Andrew Trister, who just became Verily's chief scientific officer.
Why OneOncology Is Adopting Verily’s Clinical Trial Management System
OneOncology recently announced that it is deploying Verily’s clinical trial management platform across 11 of its community oncology clinics. Adopting Verily’s software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company’s chief medical officer said.
iRhythm snags FDA approval for AFib characterization algorithm used in Verily’s wearable
Th FDA granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch. The clearance is for an algorithm that categorizes patients’ AFib by analyzing how much of it they experience over time.
Smartphones could be used to detect depression, Verily finds
A study published by Verily researchers showed that some smartphone metrics, such as sentiment in weekly voice diaries, matched up with the severity of users’ depression as determined by PHQ-9 scores. Even if these technologies could be used to track mental health, it’s not clear how they will fit into physician workflows or how comfortable people will be using their smartphones in this way.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Two Alphabet subsidiaries come together, as Onduo sends Fitbits to some of its users
People who access Onduo through their employer will have access to the wearables and Fitbit’s subscription program. Google closed its acquisition of Fitbit earlier this year, and Onduo is a subsidiary of Google's sister company, Verily.
Mayo, Verily strike two-year partnership to build decision support tools
They plan to commercialize the decision support software, which would surface relevant patient records and recommendations from Mayo Clinic specialists. To start, they will focus on cardiometabolic conditions.
Verily adds to its clinical trials toolbox with acquisition of startup SignalPath
Verily’s recent moves have signaled the company’s interest in supporting decentralized clinical trials and real-world studies. Now the life sciences subsidiary of Alphabet is bolstering its capabilities in these areas with the acquisition of startup SignalPath.
Verily, Colgate to study the link between dental and overall health
The companies will launch a randomized, controlled trial to see how access to gum irrigation and a smart toothbrush changes their oral health, blood sugar and artery health.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Highmark strikes deal with Verily as part of broader Google partnership
Verily become part of a six-year collaboration between Google Cloud and Highmark Health. A big part of the partnership will be Verily’s platform for managing chronic conditions, Onduo.
In adding more conditions, is Onduo becoming a me-too platform of Omada and Livongo?
Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?
How Verily plans to use $700M in new funding
Alphabet and other investors poured $700 million in funding into Verily last week. The company, which is Alphabet’s life sciences subsidiary, plans to pour some of the funds into supporting Covid-19 vaccine studies and programs for businesses.
Verily co-founder launches virtual specialty care startup
Tom Stanis, Verily’s co-founder and former head of software, left the Alphabet subsidiary in February to found a new healthcare startup. Called Story Health, his new startup is focused on providing care in the gaps between specialty visits.
Lessons learned from Verily’s Covid-19 testing efforts
Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.